CD151 and non-small cell lung carcinoma: The acquired outcome was in parallel with clinical studiesin the literature; a greater amount of CD151 was observed in exosomesgenerated by the NSCLC cell line A549 compared to the non-cancerouscell line; this was also validated via immunostaining.